These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22528697)

  • 21. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
    London WB; Bagatell R; Weigel BJ; Fox E; Guo D; Van Ryn C; Naranjo A; Park JR
    Cancer; 2017 Dec; 123(24):4914-4923. PubMed ID: 28885700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth patterns of human neuroblastoma xenografts and their relationship to treatment outcome.
    George BA; Yanik G; Wells RJ; Martin LW; Soukup S; Ballard ET; Gartside PS; Lampkin BC
    Cancer; 1993 Dec; 72(11):3331-9. PubMed ID: 8242560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonmetastatic thoracic neuroblastomas: a review of 40 cases.
    Rubie H; Hartmann O; Giron A; Lemoine G; Gruner M; Brugieres L; Valteau-Couanet D; Robert A; Lemerle J
    Med Pediatr Oncol; 1991; 19(4):253-7. PubMed ID: 2056969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma imaging.
    Ley S; Ley-Zaporozhan J; Günther P; Deubzer HE; Witt O; Schenk JP
    Rofo; 2011 Mar; 183(3):217-25. PubMed ID: 21170823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cerebral neuroblastoma: a case report and review.
    Etuş V; Kurtkaya O; Sav A; Ilbay K; Ceylan S
    Tohoku J Exp Med; 2002 May; 197(1):55-65. PubMed ID: 12180794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology and treatment of neuroblastoma.
    Castleberry RP
    Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroblastoma: the challenge and frustration.
    Finklestein JZ
    Hematol Oncol Clin North Am; 1987 Dec; 1(4):675-94. PubMed ID: 3323179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.
    Gustafson WC; Matthay KK
    Expert Rev Neurother; 2011 Oct; 11(10):1411-23. PubMed ID: 21955198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
    Nakagawara A; Zaizen Y; Suita S
    Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
    Twist CJ; Schmidt ML; Naranjo A; London WB; Tenney SC; Marachelian A; Shimada H; Collins MH; Esiashvili N; Adkins ES; Mattei P; Handler M; Katzenstein H; Attiyeh E; Hogarty MD; Gastier-Foster J; Wagner E; Matthay KK; Park JR; Maris JM; Cohn SL
    J Clin Oncol; 2019 Dec; 37(34):3243-3255. PubMed ID: 31386611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic neuroblastoma: low mortality and high morbidity.
    Cruccetti A; Kiely EM; Spitz L; Drake DP; Pritchard J; Pierro A
    J Pediatr Surg; 2000 May; 35(5):724-8. PubMed ID: 10813335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid tumors in children.
    Kline NE; Sevier N
    J Pediatr Nurs; 2003 Apr; 18(2):96-102. PubMed ID: 12720206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma in Turkish children: experience of a single center.
    Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of neuroblastoma in India.
    Kulkarni KP; Marwaha RK
    Indian J Pediatr; 2013 Oct; 80(10):832-7. PubMed ID: 23340984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.